Staged Versus Immediate Complete Vessel Revascularization in Patients Presenting with ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis
Abstract
INTRODUCTION In patients presenting with acute coronary syndrome (ACS) STsegment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) is the preferred modality of reperfusion. However, these patients may also have multivessel coronary artery disease (CAD) on coronary angiography, which is associated with a higher risk of mortality. Current guidelines recommend complete revascularization in STEMI patients with multivessel CAD; however, this poses a high risk of major acute cardiovascular events (MACE). Other available reperfusion strategies include staged vessel revascularization. This meta-analysis aimed to determine whether staged vessel revascularization can be a better mode of reperfusion strategy in patients with STEMI with multivessel CAD.
Methods
A comprehensive search of randomized controlled trials (RCT) was conducted with the use of staged versus immediate complete vessel revascularization in patients with STEMI. Outcome measures used to assess the effectiveness of these techniques were all-cause mortality, MACE, target vessel revascularization, and stent thrombosis. The analyses were performed using a fixed effect analysis model using the Mantel- Haenszel statistical method via Review Manager V5.4.
Results
Five studies were included in the meta-analysis with 1,483 subjects analyzed. There was a 27% lower risk of all-cause mortality (RR 0.73 [95% CI: 0.42-1.29]), 8% lower risk for MACE (RR 0.92 [95% CI: 0.60-1.39]) and in target vessel revascularization (RR 0.92 [95% CI: 0.53-1.63]), and a 29% decreased risk for stent thrombosis of staged revascularization versus immediate complete revascularization (RR 0.71 [95% CI: 0.28-1.83])
Conclusion
Staged and immediate complete vessel revascularization are the treatment strategies recommended for hemodynamically stable STEMI patients. The meta-analysis showed better clinical outcomes in the staged vessel revascularization than in immediate complete revascularization in terms of all-cause mortality, MACE, target vessel revascularization, and stent thrombosis. This study suggests that staged vessel revascularization is a preferable type of revascularization in patients presenting with STEMI with multivessel CAD.